Removing small rectal tumors with two endoscopic methods
This study compares two minimally invasive ways to remove small rectal neuroendocrine tumors (NETs), which are growths in the rectum that are usually not cancer. The goal is to find which method is safer and more effective with fewer side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have a small rectal tumor (10 mm or less) that is likely a neuroendocrine tumor.
- You are willing to have the tumor removed using one of the two procedures (UEMR or ESD).
- You do not have other serious illnesses that could shorten your life.
- You have not had surgery for this tumor before.
- You are not pregnant and do not have mental health conditions that would make it hard to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at removing small rectal neuroendocrine tumors using an endoscope (a thin camera tool) instead of open surgery. It may help people with very small tumors if the doctors think you can safely have this procedure and the cancer has not spread to lymph nodes or distant organs.
This trial tests two endoscopic techniques (mEMR-C and mEMR-L) to remove small rectal neuroendocrine tumors. It may help patients with tumors 10 mm or smaller who want a less invasive treatment option.
This trial tests a new robotic system to remove large, flat growths in the rectum without traditional surgery. It may help people who have early-stage rectal tumors that are too big for standard removal methods.
This trial tests a new robotic system (Endorobotics) to remove early-stage stomach or colon tumors using an endoscope (a thin, flexible tube with a camera). The goal is to see if the robot helps doctors remove the entire tumor safely and effectively, especially when standard methods are challenging.
This trial tests how well a precise surgery removes the remaining rectal cancer after you have had radiation and chemotherapy. It is for people whose tumor has shrunk a lot but is still there, and the tumor is very low in the rectum.
This study compares two minimally invasive endoscopic techniques—ESD and EPMR—for removing small neuroendocrine tumors (slow-growing hormone-producing tumors) in the rectum. The goal is to see which approach works better and is safer for patients.
Hear when a new Rectal Neuroendocrine Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.